Status:
COMPLETED
Study of S-3304 in Patients With Locally Advanced Non-Small Cell Lung Cancer
Lead Sponsor:
Shionogi
Conditions:
Non Small Cell Lung Cancer
Lung Cancer
Eligibility:
All Genders
18-85 years
Phase:
PHASE1
PHASE2
Brief Summary
A study to measure the safety and effectiveness of S-3304 when given in combination with conventional chemo-radiation therapy in patients with locally advanced non-small cell lung cancer.
Detailed Description
A two part study to evaluate the safety and efficacy of S-3304 in combination with standard therapy in patients with locally advanced non-small cell lung cancer. The first part of the study is a Phase...
Eligibility Criteria
Inclusion
- INCLUSION CRITERIA
- newly diagnosed non-small cell lung cancer of stage IIIA non-resectable or of stage IIIB without pleural effusion
- ECOG performance status 0-1
- adequate organ function
- clinically indicated and able to receive conventional chemoradiation therapy
- EXCLUSION CRITERIA
- patients with prior history of cancer, other than basal cell carcinoma after appropriate treatment, or prior systemic chemotherapy treatment
- patients with other serious intercurrent illness including HIV/AIDS, or contraindicated for paclitaxel/carboplatin or thoracic irradiation treatment
Exclusion
Key Trial Info
Start Date :
February 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 26 2006
Estimated Enrollment :
9 Patients enrolled
Trial Details
Trial ID
NCT00078390
Start Date
February 1 2003
End Date
October 26 2006
Last Update
May 2 2018
Active Locations (5)
Enter a location and click search to find clinical trials sorted by distance.
1
Scripps Cancer Institute
La Jolla, California, United States, 92037
2
Lombardi Cancer Center
Washington D.C., District of Columbia, United States, 20007
3
University of Kansas Cancer Center
Kansas City, Kansas, United States, 66160
4
VA Medical Center-East Orange (study available to veterans only)
East Orange, New Jersey, United States, 07108